FIELD: chemistry.
SUBSTANCE: invention relates to pyrrolidine derivatives of formula: where: each of R1, R2, R3, R4, R5 and R6 independently denotes H, C1-10alkyl; R7 denotes C1-10alkyl, a 5-6-member monocyclic aromatic heteroaryl, having one or two heteroatoms selected from N, S, optionally substituted with C1-10alkyl; R denotes H, C1-10alkyl; or R7 and R8, together with a N with which they are attached, form a 5-8-member monocyclic, saturated or unsaturated ring, optionally including a second hateroatom selected from N, S, O, optionally substituted with a halogen, CN, -OR', C1-10alkyl, hydroxyC1-10alkyl, C1-10alkoxyC1-10alkyl, -S(O)2R', -C(O)OR', or form a 8-12-member bicyclic, saturated or unsaturated ring; R' denotes H, C1-10alkyl; m and n are independently equal to 0, 1, 2 or 3; X denotes NRa, Ra denotes H. The compounds are used in a method of inhibiting dipeptidyl peptidase IV.
EFFECT: obtaining pyrrolidine derivatives.
13 cl, 2 dwg, 1 tbl, 26 ex
Title | Year | Author | Number |
---|---|---|---|
DIPEPTIDYL PEPTIDASE-IV INHIBITORS | 2010 |
|
RU2574410C2 |
DERIVATIVE OF 2-CYANO-4-FLUOROPYRROLIDINE AND ITS SALT | 2003 |
|
RU2288222C2 |
ANTIVIRAL COMPOUNDS | 2010 |
|
RU2541571C2 |
DICYCLOAZAALKANE DERIVATIVES, METHODS FOR PRODUCTION THEREOF AND USE THEREOF IN MEDICINE | 2008 |
|
RU2487866C2 |
QUINAZOLINE DERIVATIVES INHIBITING EGFR ACTIVITY | 2009 |
|
RU2505534C2 |
VITAMIN D DERIVATIVE CONTAINING CYCLIC AMINE IN SIDE CHAIN | 2021 |
|
RU2819389C1 |
CYCLOPROPYLAMIDE DERIVATIVES AS N-HISTAMINE RECEPTOR MODULATORS | 2007 |
|
RU2449989C2 |
PURINE INHIBITORS OF HUMAN PHOSPHATIDYLINOSITOL 3-KINASE DELTA | 2013 |
|
RU2658006C2 |
COMPOUNDS AND COMPOSITIONS USED FOR TREATMENT OF NTRK-RELATED DISORDERS | 2016 |
|
RU2744974C2 |
PYRIDO[3,4-D]PYRIMIDINE DERIVATIVE AND ITS PHARMACEUTICALLY ACCEPTABLE SALT | 2017 |
|
RU2796400C2 |
Authors
Dates
2013-09-27—Published
2009-02-25—Filed